Privia Health Group, Inc. (PRVA)
NASDAQ (NGS) NASDAQ (NGS) Primary 
Privia Health's Premium: A Breakout Play
Privia Health Group offers high-growth potential with a recurring revenue model and strong relationships, making it attractive amid the healthcare sector underperformance. PRVA's recent acquisition of Evolent Health's ACO adds over 120,000 users, boosting revenue streams and raising expectations for the next earnings report. Despite a high forward P/E and a DCF model suggesting downside, technical patterns and sector comps support a potential breakout above $26, targeting $28–$36.
Privia Health Group, Inc. (PRVA) Q2 2025 Earnings Call Transcript
Privia Health Group, Inc. (NASDAQ:PRVA ) Q2 2025 Earnings Conference Call August 7, 2025 8:00 AM ET Company Participants David Mountcastle - Executive VP, CFO & Principal Accounting Officer Parth Mehrotra - CEO & Director Robert P. Borchert - Senior Vice President of Investor Relations & Corporate Communications Conference Call Participants Albert J.
Compared to Estimates, Privia Health (PRVA) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Privia Health (PRVA) Misses Q2 Earnings Estimates
Privia Health (PRVA) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.03 per share a year ago.
Privia Health Group, Inc. (PRVA) Q1 2025 Earnings Call Transcript
Privia Health Group, Inc. (NASDAQ:PRVA ) Q1 2025 Earnings Conference Call May 8, 2025 8:00 AM ET Company Participants Robert Borchert - Senior Vice President-Investor and Corporate Communications Parth Mehrotra - Chief Executive Officer David Mountcastle - Chief Financial Officer Conference Call Participants Jailendra Singh - Truist Josh Raskin - Nephron Research Richard Close - Canaccord Matthew Gillmor - KeyBanc Jessica Tassan - Piper Sandler Alberta Massey - Leerink Partners A.J. Rice - UBS Thomas Walsh - Barclays Ryan Langston - TD Cowen Elizabeth Anderson - Evercore ISI Constantine Davides - Citizens JMP Jack Slevin - Jefferies Jeff Garro - Stephens Ryan Daniels - William Blair David Larsen - BTIG Matt Shea - Needham Jamie Perse - Goldman Sachs Daniel Grosslight - Citi Michael Ha - Baird Joanna Gajuk - Bank of America Operator Thank you for standing by.
Privia Health (PRVA) Reports Q1 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Privia Health (PRVA) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Privia Health (PRVA) Misses Q1 Earnings Estimates
Privia Health (PRVA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.02 per share a year ago.
Countdown to Privia Health (PRVA) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS
Get a deeper insight into the potential performance of Privia Health (PRVA) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Here's What Key Metrics Tell Us About Privia Health (PRVA) Q4 Earnings
Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Privia Health Group, Inc. (PRVA) Q4 2024 Earnings Call Transcript
Privia Health Group, Inc. (NASDAQ:PRVA ) Q4 2024 Earnings Conference Call February 27, 2025 8:00 AM ET Company Participants Robert Borchert - Senior Vice President-Investor & Corporate Communications Parth Mehrotra - Chief Executive Officer David Mountcastle - Chief Financial Officer Conference Call Participants Sameer Patel - Evercore ISI Andrew Mok - Barclays Josh Raskin - Nephron Research Whit Mayo - Leerink Partners Jailendra Singh - Truist Securities A.J. Rice - UBS Jack Slevin - Jeffries Jeff Garro - Stephens Inc Matthew Gillmor - KeyBanc Richard Close - Canaccord Genuity Matt Shea - Needham Ryan Langston - TD Cowen David Larsen - BTIG Adam Ron - Bank of America Michael Ha - Baird Constantine Davides - Citizens JMP Daniel Grosslight - Citi Jessica Tassan - Piper Sandler Tao Qiu - Macquarie Craig Jones - Stifel Operator Thank you for standing by.
Privia Health (PRVA) Lags Q4 Earnings Estimates
Privia Health (PRVA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.02 per share a year ago.
Seeking Clues to Privia Health (PRVA) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Privia Health (PRVA), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2024.
